Skip to content

Work Activity Augmented by Cognitive Rehabilitation for Schizophrenia

Work Activity Augmented by Cognitive Rehabilitation: Continuation and Follow-up

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00430560
Enrollment
150
Registered
2007-02-02
Start date
2000-10-31
Completion date
2015-10-31
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizoaffective Disorder, Schizophrenia

Keywords

work therapy, cognitive rehabilitation, schizophrenia, schizoaffective disorder, treatment outcome

Brief summary

This research investigates the benefits of productive activity and cognitive rehabilitation for patients with schizophrenia. Key questions are: 1. does cognitive rehabilitation plus work activity produce better outcomes than work activity alone? 2. Is cognitive rehabilitation more helpful for individuals with moderate or greater cognitive impairment than for individuals without such impairment? 3. Does cognitive rehabilitation reduce the dropout rate and increase participation in work activity for cognitively impaired subjects? 4. What features of cognitive rehabilitation are most important for clinical and rehabilitation outcomes?

Detailed description

This is a randomized, matching study in which subjects are stratified by degree of cognitive impairment, then randomly assigned to one of two conditions: Work Services Only vs. Work Services plus cognitive rehabilitation. Longitudinal analysis of work activity, work performance, symptoms, quality of life, cognitive function and service utilization are made.

Interventions

BEHAVIORALcognitive rehabilitation

computer training

PROCEDUREwork therapy

opportunity to work in carefully supervised hospital job

Sponsors

VA Connecticut Healthcare System
CollaboratorFED
VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* diagnosis of schizophrenia or schizoaffective disorder

Exclusion criteria

* change in psychiatric medications or housing within 30 days of study intake * episode of drug abuse within 30 days of study intake * GAF score 30 or less * known neurological disease or developmental disability

Design outcomes

Primary

MeasureTime frame
Neuropsychological test performancedata collection completed

Secondary

MeasureTime frame
Hours of productive activitydata collection completed
Hours workeddata collection completed
Quality of lifedata collection completed
Psychiatric symptomsdata collection completed

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026